Starling Oncology, Inc. · Brief

Next report

12 days

Nov 12 · after closeest.Q3 FY26

Expected move

±16.6%implied · straddle

5.457.61

spot 6.53exp Nov 20ATM strike 7ATM straddle 1.27IV 95%

Oct 30 close

Expected move

No reported quarters.

Nov 12 report · est.

—

STLN report session

No linked exposure.

Oct 29impliedImplied move: ±20.8% into Nov 12 earnings (Oct 29 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.